IPSEN, OOO
- Country
- 🇷🇺Russia
- Ownership
- -
- Established
- 1929-01-01
- Employees
- 5.7K
- Market Cap
- $9.8B
- Website
- https://www.ipsen.com/
Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2007-07-12
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 40
- Registration Number
- NCT00500500
- Locations
- 🇫🇷
Hôpital La Timone, Marseille, France
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 117
- Registration Number
- NCT00489255
- Locations
- 🇺🇸
Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸Parkinson's Disease and Movement Disorders Center of Long Island, Commack, New York, United States
🇺🇸Kingston Neurological Associates, Kingston, New York, United States
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
- Conditions
- First Posted Date
- 2007-04-04
- Last Posted Date
- 2019-01-14
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 546
- Registration Number
- NCT00455884
- Locations
- 🇬🇧
Ipsen Central Contact, Slough, Berkshire, United Kingdom
A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders
- Conditions
- First Posted Date
- 2007-04-04
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 3690
- Registration Number
- NCT00455728
- Locations
- 🇬🇧
Ipsen Central Contact, Slough, Berkshire, United Kingdom
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
- First Posted Date
- 2007-04-04
- Last Posted Date
- 2019-08-02
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 6
- Registration Number
- NCT00455637
- Locations
- 🇬🇧
Chailey Heritage Clinical Services, Chailey, United Kingdom
Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
- Conditions
- Interventions
- First Posted Date
- 2007-03-15
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 40
- Registration Number
- NCT00447876
- Locations
- 🇩🇪
University Hospital Charite, Campus Virchow, Musculoskeletal Centre, Orthopedic Clinic, Berlin, Germany
🇩🇪Orthopedic Practice Biberburg, Berlin, Germany
🇩🇪Klinik für Orthopädie und Rheumatologie, Universitätsklinikum Gießen und Marburg GmbH, Marburg, Germany
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
- First Posted Date
- 2007-03-15
- Last Posted Date
- 2023-03-30
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 516
- Registration Number
- NCT00447772
- Locations
- 🇩🇪
Städt. Krankenhaus Martha-Maria, Halle, Germany
🇩🇪Gemeinschaftspraxis für Neurologie/Psychiatrie, Lüneburg, Germany
🇩🇪Westpfalz-Klinikum GmbH, Kaiserslautern, Germany
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
- Conditions
- Interventions
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 59
- Registration Number
- NCT00447499
- Locations
- 🇺🇸
Research Institute of Dallas, Dallas, Texas, United States
🇺🇸Northwestern University The Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 25
- Registration Number
- NCT00444639
- Locations
- 🇳🇱
AMC Amsterdam, Amsterdam, Netherlands
🇳🇱Diaconessenhuis Leiden, Leiden, Netherlands
🇳🇱Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
- Conditions
- Interventions
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 38
- Registration Number
- NCT00444873
- Locations
- 🇩🇪
Klinikum Innenstadt, Munich, Germany